Cited by 774Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 173 of the 175 references it cites were found in a registry or an index.

Molecular mechanisms of neurodegeneration in Alzheimer's disease

Open access

Crews, L., Masliah, E.·2010·Human Molecular Genetics

DOI 10.1093/hmg/ddq160PMC PMC2875049

Open this paper in CoChat — free account Open PDF

Abstract

Alzheimer's disease (AD) is characterized by cognitive impairment, progressive neurodegeneration and formation of amyloid-beta (Abeta)-containing plaques and neurofibrillary tangles composed of hyperphosphorylated tau. The neurodegenerative process in AD is initially characterized by synaptic damage accompanied by neuronal loss. In addition, recent evidence suggests that alterations in adult neurogenesis in the hippocampus might play a role. Synaptic loss is one of the strongest correlates to the cognitive impairment in patients with AD. Several lines of investigation support the notion that the synaptic pathology and defective neurogenesis in AD are related to progressive accumulation of Abeta oligomers rather than fibrils. Abnormal accumulation of Abeta resulting in the formation of toxic oligomers is the result of an imbalance between the levels of Abeta production, aggregation and clearance. Abeta oligomers might lead to synaptic damage by forming pore-like structures with channel activity; alterations in glutamate receptors; circuitry hyper-excitability; mitochondrial dysfunction; lysosomal failure and alterations in signaling pathways related to synaptic plasticity, neuronal cell and neurogenesis. A number of signaling proteins, including fyn kinase; glycogen synthase kinase-3beta (GSK3beta) and cyclin-dependent kinase-5 (CDK5), are involved in the neurodegenerative progression of AD. Therapies for AD might require the development of anti-aggregation compounds, pro-clearance pathways and blockers of hyperactive signaling pathways.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/hmg/ddq160

Cites

173 of 173 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
The Ki-67 protein: From the known and the unknown
Scholzen, T. E., & Gerdes, J. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200003)182:3 · Cited by 4,707
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Self-citation
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
More hippocampal neurons in adult mice living in an enriched environment
Kempermann, G., Kuhn, H. G., & Gage, F. H. (1997) · Nature · doi:10.1038/386493a0 · Cited by 3,586
Mechanisms and Functional Implications of Adult Neurogenesis
Zhao, C., Deng, W., & Gage, F. H. (2008) · Cell · doi:10.1016/j.cell.2008.01.033 · Cited by 3,007
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Self-citation
Neurodegenerative Tauopathies
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480

Show all 175 references

Research works printed but not linked: 9

1998, Trends in cell biology, 8, 125
2004, 127, 601
1997, 19, 939
2003, 37, 925
2006, 52, 831
2007, 55, 697
Smith, 2001, Cell Growth & Differentiation, 12, 277
1997, 18, 29
2005, 48, 825

Sorted by citations

Items 201–300 of 774

Age Progression of Neuropathological Markers in the Brain of the Chilean Rodent Octodon degus, a Natural Model of A lzheimer's Disease
Inestrosa, N. C., Ríos, J. A., Cisternas, P., Tapia‐Rojas, C., Rivera, D. S., Braidy, N., Zolezzi, J. M., Godoy, J. A., Carvajal, F. J., Ardiles, Á. O., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12226 · Cited by 47
“Moreover, the overexpression of human transgenes in a nonphysiological scenario strongly influences the onset of histopathological features and cognitive decline observed in AD (16, 58).”
Background
Insights from Caenorhabditis elegans on the role of metals in neurodegenerative diseases
Martinez‐Finley, E. J., Ávila, D. S., Chakraborty, S., & Aschner, M. (2011) · Metallomics · doi:10.1039/c0mt00064g · Cited by 43
Metformin in Alzheimer’s disease: An overview of potential mechanisms, preclinical and clinical findings
Khezri, M. R., Yousefi, K., Mahboubi, N., Hodaei, D., & Ghasemnejad‐Berenji, M. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114945 · Cited by 43
Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease
Rockenstein, E. M., Desplats, P., Ubhi, K. K., Mante, M., Florio, J. B., Adame, A., Winter, S., Brandstaetter, H., Meier, D., & Masliah, E. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.04.008 · Cited by 42
“Moreover previous studies have shown that CBL reduces Aβ production by reducing maturation of APP mediated by CDK5 and GSK3β activation (Rockenstein et al., 2006).”
BackgroundInfluentialSelf-citation
Protective effect of betulinic acid against intracerebroventricular streptozotocin induced cognitive impairment and neuronal damage in rats: Possible neurotransmitters and neuroinflammatory mechanism
Kaundal, M., Deshmukh, R. R., & Akhtar, M. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.11.020 · Cited by 42
Motor deficits in 16-month-old male and female 3xTg-AD mice
Montbrun, T. G.-D., Fertan, E., Stover, K. R., & Brown, R. E. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.09.006 · Cited by 45
“Cognitive impairments in AD patients are strongly correlated with synaptic loss in the hippocampus, neocortex and limbic system [26] but AD pathologies also accumulate in brain areas controlling motor function, including the primary motor cortex, striatum and substantia nigra [27,28].”
Infrared neuromodulation:a neuroengineering perspective
Fekete, Z., Horváth, Á. C., & Zátonyi, A. (2020) · Journal of Neural Engineering · doi:10.1088/1741-2552/abb3b2 · Cited by 40
Alzheimer’s Disease and Protein Kinases
Engin, A. B., & Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_11 · Cited by 43
Plasma lncRNA profiling identified BC200 and NEAT1 lncRNAs as potential blood-based biomarkers for late-onset Alzheimer’s disease
Khodayi-Shahrak, M., Khalaj‐Kondori, M., Feizi, M. A. H., Bonyadi, M. J., & Talebi, M. (2022) · EXCLI journal · doi:10.17179/excli2022-4764 · Cited by 42
“A number of cellular and molecular changes such as genetic alterations, are involved in the development of AD (Crews and Masliah, 2010; Guo et al., 2020; Mehdizadeh et al., 2019; Talebi et al., 2020).”
Background
Neuroprotective effects of liquiritin on cognitive deficits induced by soluble amyloid-β1–42 oligomers injected into the hippocampus
Jia, S., Wu, X., Li, X., Dai, X., Gao, Z., Zheng, L., Zheng, Q., & Sun, Y. (2016) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2016.1201811 · Cited by 41
Hippocampal Stratum Radiatum, Lacunosum, and Moleculare Sparing in Mild Cognitive Impairment
Su, L., Hayes, L., Soteriades, S., Williams, G. B., Brain, S., Firbank, M., Longoni, G., Arnold, R. J., Rowe, J. B., & O'Brien, J. T. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170344 · Cited by 41
“This may be due to later changes associated with the transition from MCI to AD, and represents the wider spread of pathological change associated with the clinical expression of AD dementia [36].”
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity
Severini, C., Lattanzi, R., Maftei, D., Marconi, V., Ciotti, M. T., Passeri, P. P., Florenzano, F., DUCA, E. D., Caioli, S., Zona, C., et al. (2015) · Scientific Reports · doi:10.1038/srep15301 · Cited by 40
“Neuropathological hallmarks of AD correlate with the presence of soluble A β oligomers as the principal neurotoxic agent 30,31 .”
Dysregulation and Diagnostic Potential of microRNA in Alzheimer’s Disease
Pan, Y., Liu, R., Terpstra, E., Wang, Y., Qiao, F., Wang, J., Tong, Y., & Pan, B. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150451 · Cited by 29
“Neurite and synapse destruction occur in the early stages of AD followed by neuron loss [112].”
Background
Intranasal administration of TAT-haFGF14–154 attenuates disease progression in a mouse model of Alzheimer’s disease
Lou, G., ZHANG, Q.-H., Xiao, F., Xiang, Q., Su, Z., Zhang, L., Yang, P., Yang, Y. F., Zheng, Q., & Huang, Y. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.003 · Cited by 40
Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease
Galván, V., & Hart, M. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.010 · Cited by 41
Alzheimer’s Disease Associated Genes Ankyrin and Tau Cause Shortened Lifespan and Memory Loss in Drosophila
Higham, J. P., Malik, B. R., Buhl, E., Dawson, J., Ogier, A. S., Lunnon, K., & Hodge, J. J. L. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00260 · Cited by 40
“…in these rodents have not translated to any new successful treatments for AD highlighting the need to generate and characterize new models of sporadic AD (McGowan et al., 2006; Crews and Masliah, 2010; Van Dam and De Deyn, 2011; Gama Sosa et al., 2012; Guo et al., 2012; De Jager et al., 2014).”
Background
Unveiling the Complex Role of Exosomes in Alzheimer’s Disease
Sun, M., & Chen, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s466821 · Cited by 39
Decreased dendritic spine density and abnormal spine morphology in Fyn knockout mice
Babus, L. W., Little, E. M., Keenoy, K. E., Minami, S., Chen, E., Song, J. M., Caviness, J., Koo, S. Y., Pak, D. T. S., Rebeck, G. W., et al. (2011) · Brain Research · doi:10.1016/j.brainres.2011.07.059 · Cited by 38
Puerarin Ameliorates D-Galactose Induced Enhanced Hippocampal Neurogenesis and Tau Hyperphosphorylation in Rat Brain
Hong, X.-P., Chen, T., Yin, N., Han, Y., Yuan, F., Duan, Y., Shen, F., Zhang, Y., & Chen, Z. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150566 · Cited by 39
“The dementia in AD is characterized by progressive neuronal loss, formation of amyloid-(cid:2) (A (cid:2) )-containing plaques, and the presence of neuroﬁbrillary tangles (NFT) composed of hyperphosphorylated tau [1].”
Astrocytic GluN2A and GluN2B Oppose the Synaptotoxic Effects of Amyloid-β1-40 in Hippocampal Cells
Li, Y., Chang, L., Song, Y., Gao, X., Roselli, F., Liu, J., Zhou, W., Fang, Y., Wei, L., Li, H., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160297 · Cited by 37
“It is a chronic neurodegenerative disease that develops over many decades, with subtle synaptic dysfunction occurring well before overt neuronal loss and behavioral symptoms are detectable [1–4].”
Background
Modulation of Alzheimer's amyloid β peptide oligomerization and toxicity by extracellular Hsp70
Rivera, I., Capone, R. F., Cauvi, D. M., Arispe, N. J., & Maio, A. D. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0839-0 · Cited by 41
“Aβ peptide cytotoxicity has been associated with increases in intracellular calcium levels, production of oxygen radicals, lipid peroxidation, mitochondrial dysfunction, and inflammation (Crews and Masliah 2010; Lobello et al. 2012).”
BackgroundInfluential
Molecular Bases of Alzheimer’s Disease and Neurodegeneration: The Role of Neuroglia
Luca, A., Calandra, C., & Luca, M. (2018) · Aging and Disease · doi:10.14336/ad.2018.0201 · Cited by 42
“Amyloid pathology leads to synaptic dysfunctions and glial alterations through different mechanisms, among which disruption of Ca2+ signaling, activation of immunoproteasome, induction of glutamate neurotoxicity, mitochondrial dysfunction and alteration of the signaling pathways involved in synaptic plasticity and neu…”
Background
Imaging Mass Spectrometry: A New Tool to Assess Molecular Underpinnings of Neurodegeneration
Chen, K., Baluya, D. L., Tosun, M., Li, F., & Maletić‐Savatić, M. (2019) · Metabolites · doi:10.3390/metabo9070135 · Cited by 41
Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease
Talebi, M., Kakouri, E., Talebi, M., Tarantilis, P. Α., Farkhondeh, T., İlgün, S., Pourbagher‐Shahri, A. M., & Samarghandian, S. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1923479 · Cited by 41
“Numerous protein kinases and protein phosphatases have been involved in the irregular phosphorylation of tau comprising glycogen synthase kinase-3 beta (GSK-3β), cyclin-dependent kinase 5 (CDK-5), mitogen-activated protein kinase (MAPK), calcium-calmodulin kinase, and protein kinase C (PKC) [48,49].”
Background
Saponins and flavonoids from Bacopa floribunda plant extract exhibit antioxidant and anti-inflammatory effects on amyloid beta 1-42-induced Alzheimer's disease in BALB/c mice
Oyeleke, M. B., & Owoyele, B. V. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.114997 · Cited by 38
AI-DrugNet: A network-based deep learning model for drug repurposing and combination therapy in neurological disorders
Pan, X., Yun, J., Coban‐Akdemir, Z., Jiang, X., Wu, E., Huang, J. H., Sahni, N., & Yi, S. S. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.02.004 · Cited by 36
CaMKII-dependent dendrite ramification and spine generation promote spatial training-induced memory improvement in a rat model of sporadic Alzheimer's disease
Jiang, X., Chai, G., Wang, Z.-H., Hu, Y., Li, X., Ma, Z., Wang, Q., Wang, J., & Liu, G. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.018 · Cited by 37
“We also found that there is a strong positive correlationship between memory abilities and spine density in DG neurons, which conforms with the studies, that synaptic loss is the major neurobiological substrate of cognitive dysfunction and one of the strongest correlates to the cognitive impairment in patients with AD…”
Result
Molecular Signaling Pathways Behind the Biological Effects ofSalviaSpecies Diterpenes in Neuropharmacology and Cardiology
Akaberi, M., Iranshahi, M., & Mehri, S. (2016) · Phytotherapy Research · doi:10.1002/ptr.5599 · Cited by 38
“Different mechanisms are involved in the formation and progression of this disorder (Selkoe, 1999; Crews and Masliah, 2010; Pleckaityte, 2010).”
Background
Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer’s Disease
Piemontese, L., Vitucci, G., Catto, M., Laghezza, A., Perna, F. M., Rullo, M., Loiodice, F., Capriati, V., & Solfrizzo, M. (2018) · Molecules · doi:10.3390/molecules23092182 · Cited by 38
Examining the link between dose-dependent dietary iron intake and Alzheimer’s disease through oxidative stress in the rat cortex
Ceylan, H., Budak, H., Koçpınar, E. F., Baltacı, N. G., & Erdoğan, O. (2019) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2019.09.002 · Cited by 38
Synaptic dysregulation and hyperexcitability induced by intracellular amyloid beta oligomers
Fernández-Pérez, E. J., Muñoz, B., Bascuñán, D., Peters, C., Riffo-Lepe, N., Flores-Espinoza, M. P., Morgan, P. J., Filippi, C., Bourboulou, R., Sengupta, U., et al. (2021) · Aging Cell · doi:10.1111/acel.13455 · Cited by 38
“…2013; Olloquequi et al., 2018) together with vesicular depletion, decreased phosphorylation, and localization of the AMPA and NMDA receptor in synapses when Aβ is present in the extracellular milieu over extended periods of time [for review see (Crews & Masliah, 2010; Marsh & Alifragis, 2018)].”
Background
Memory related molecular signatures: The pivots for memory consolidation and Alzheimer's related memory decline
Kaushik, M., Kaushik, P., & Parvez, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101577 · Cited by 39
Effects of chronic variable stress on cognition and Bace1 expression among wild-type mice
Cordner, Z. A., & Tamashiro, K. L. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.127 · Cited by 38
Investigating Interventions in Alzheimer's Disease with Computer Simulation Models
Proctor, C. J., Boche, D., Gray, D. A., & Nicoll, J. A. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073631 · Cited by 38
“Alzheimer’s disease (AD) is characterised by aggregation of Ab and tau proteins in the brain accompanied by glial cell activation together with synaptic and neuronal loss (reviewed in [1]).”
Derivatives and Analogues of Resveratrol: Recent Advances in Structural Modification
Li, Q., Li, Y., Deora, G. S., & Ruan, B. (2019) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557519666190128093840 · Cited by 36
Beta-amyloid peptides undergo regulated co-secretion with neuropeptide and catecholamine neurotransmitters
Toneff, T., Funkelstein, L., Mosier, C., Abagyan, A., Ziegler, M., & Hook, V. (2013) · Peptides · doi:10.1016/j.peptides.2013.04.020 · Cited by 32
“Beta-amyloid peptides (Aβ) are a major factor involved in the development of neurodegeneration of Alzheimer's disease (AD), resulting in severe loss of memory and cognitive functions [6,13,18,51,53].”
Background
Cytotoxic Effects of Environmental Toxins on Human Glial Cells
D‘Mello, F., Braidy, N., Marçal, H., Guillemin, G. J., Rossi, F., Chinian, M., Laurent, D., Teo, C., & Neilan, B. A. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9678-5 · Cited by 36
“…neurotransmitters and the ions which regulate them are produced in excess, eventually leading to cell death; DNA damage; abnormal protein accumulation in nervous tissue; and an increase in apoptosis (Crews and Masliah 2010, Heneka et al. 2010, Lau and Tymianski 2010, Wang and Michaelis 2010).”
Background
Effective expression of Drebrin in hippocampus improves cognitive function and alleviates lesions of Alzheimer's disease in APP (swe)/ PS 1 (ΔE9) mice
Liu, Y., Xu, Y., Zhang, L., Huang, L., Yü, P., Zhu, H., Deng, W., & Qin, C. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12706 · Cited by 35
Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer's disease
Singh, A., & Verma, S. (2020) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_999_19 · Cited by 36
Age and gender differences for the behavioral phenotypes of 3xTg alzheimer's disease mice
Pairojana, T., Phasuk, S., Suresh, P., Huang, S., Pakaprot, N., Chompoopong, S., Hsieh, T., & Liu, I. Y. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147437 · Cited by 42
NR2B-Containing NMDA Receptors Expression and Their Relationship to Apoptosis in Hippocampus of Alzheimer’s Disease-Like Rats
Liu, Z., Lv, C., Zhao, W., Song, Y., Pei, D., & Xu, T. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0726-0 · Cited by 36
“phorylated tau [4, 5].”
Background
Multifunctional Liposomes Targeting Amyloid‐β Oligomers for Early Diagnosis and Therapy of Alzheimer's Disease
Senapati, S., Tripathi, K. K., Awad, K., & Rahimipour, S. (2024) · Small · doi:10.1002/smll.202311670 · Cited by 39
Amyloid β-Mediated Zn2+ Influx into Dentate Granule Cells Transiently Induces a Short-Term Cognitive Deficit
Takeda, A., Nakamura, M., Fujii, H., Uematsu, C., Minamino, T., Adlard, P. A., Bush, A. I., & Tamano, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115923 · Cited by 35
Role of APP Interactions with Heterotrimeric G Proteins: Physiological Functions and Pathological Consequences
Copenhaver, P. F., & Kögel, D. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00003 · Cited by 35
“Since GSK3β activity is increased in the AD brain (Crews and Masliah, 2010; Jimenez et al., 2011; Llorens-Martin et al., 2014), we hypothesize that the decline in sAPPα levels associated with both sporadic AD and FAD contributes to this phenomenon (Almkvist et al.”
Background
Benzimidazole-derived Compounds Designed for Different Targets of Alzheimer’s Disease
Gülcan, H. O., Mavideniz, A., Sahin, M. F., & Orhan, İ. E. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190124123208 · Cited by 35
Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity
Vera, D. M., Rosell‐Valle, C., López-Gambero, A. J., Navarro, J. A., Zambrana-Infantes, E. N., Rivera, P., Santín, L. J., Suárez, J., & de Fonseca, F. R. (2020) · Biology · doi:10.3390/biology9110377 · Cited by 35
New Th2 adjuvants for preventive and active immunotherapy of neurodegenerative proteinopathies
Marciani, D. J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.015 · Cited by 34
Machine learning in Alzheimer’s disease drug discovery and target identification
Geng, C., Wang, Z., & Tang, Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102172 · Cited by 34
First BRET‐based screening assay performed in budding yeast leads to the discovery of CDK5/p25 interaction inhibitors
Corbel, C., Wang, Q., Bousserouel, H., Hamdi, A., Zhang, B., Lozach, O., Ferandin, Y., Tan, V. B. C., Guéritte, F., Colas, P., et al. (2011) · Biotechnology Journal · doi:10.1002/biot.201100138 · Cited by 35
“It plays an important role in synaptic plasticity and neuronal development [3].”
Background
Oxidative Stress in Neurodegenerative Disorders: A Key Driver in Impairing Skeletal Muscle Health
Castelli, S., Carinci, E., & Baldelli, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125782 · Cited by 36
A Peptide That Binds Specifically to the β-Amyloid of Alzheimer's Disease: Selection and Assessment of Anti-β-Amyloid Neurotoxic Effects
Wang, F., Zhou, X., Yang, Q., Xu, W., Wang, F., Chen, Y., & Chen, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027649 · Cited by 35
“The most aggregation-prone form, Ab1-42, which is the predominant and initial species deposited in the brain parenchyma, is considered to be the major pathogenic form in AD [5].”
Background
MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease
Raffaele, I., Silvestro, S., & Mazzon, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054736 · Cited by 33
“Although AD usually occurs in a sporadic form in people > 65 years of age, a small percentage of patients develop earlier onset associated with mutations in different genes, including APP, PSEN2, and PSEN1 (encoding, respectively, amyloid precursor protein, presenilin-1, and presenilin-2) [57].”
Background
Soluble Alpha-APP (sAPPalpha) Regulates CDK5 Expression and Activity in Neurons
Hartl, D., Klatt, S., Roch, M., Konthur, Z., Klose, J., Willnow, T. E., & Rohe, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065920 · Cited by 33
“Interestingly, CDK5 and CRMP2 were previously associated with AD pathology [27,28].”
Background
Zebrafish as a Promising Tool for Modeling Neurotoxin-Induced Alzheimer’s Disease
Thawkar, B. S., & Kaur, G. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00343-z · Cited by 36
“This damage might have encouraged alterations in glutamate receptors, circuit hyperexcitability, and signaling pathways associated with synaptic plasticity (Crews and Masliah 2010).”
Background
Administering crocin ameliorates anxiety‐like behaviours and reduces the inflammatory response in amyloid‐beta induced neurotoxicity in rat
Hadipour, M., Bahari, Z., Afarinesh, M. R., Jangravi, Z., Shirvani, H., & Meftahi, G. H. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13494 · Cited by 33
Modulation of amyloid-β aggregation by metal complexes with a dual binding mode and their delivery across the blood–brain barrier using focused ultrasound
Chan, T. G., Rühl, C. L., Morse, S. V., Simon, M., Rakers, V., Watts, H. R., Aprile, F. A., Choi, J. J., & Vilar, R. (2021) · Chemical Science · doi:10.1039/d1sc02273c · Cited by 33
Green tea, epigallocatechin gallate and the prevention of Alzheimer’s disease: Clinical evidence
Lange, K. W., Lange, K. M., & Nakamura, Y. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.03.002 · Cited by 34
Discovery of novel imidazole chemotypes as isoform-selective JNK3 inhibitors for the treatment of Alzheimer's disease
Jun, J., Yang, S., Lee, J.-H., Moon, H., Kim, J., Jung, H., Im, D., Oh, Y., Jang, M., Cho, H., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114894 · Cited by 33
Okadaic acid induced neurotoxicity leads to central cholinergic dysfunction in rats
Kamat, P. K., Tota, S., Rai, S., Shukla, R., Ali, S., Najmi, A. K., & Nath, C. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.06.006 · Cited by 33
“Brain tissue from patients with dementia was examined for activities of choline acetyltransferase and acetylcholinesterase activities, which were decreased significantly in demented subjects (Crews and Masliah, 2010).”
Background
Occupational metals exposure and cognitive performance among foundry workers using tau protein as a biomarker
Mohammed, R. S., Ibrahim, W., Sabry, D., & El-Jaafary, S. I. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.09.017 · Cited by 33
A Small Compound Targeting Prohibitin with Potential Interest for Cognitive Deficit Rescue in Aging mice and Tau Pathology Treatment
Guyot, A.-C., Leuxe, C., Disdier, C., Oumata, N., Costa, N., Roux, G. L., Varela, P. F., Duchon, A., Charbonnier, J., Hérault, Y., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-57560-3 · Cited by 33
YKL-40 and neuron-specific enolase in neurodegeneration and neuroinflammation
Dichev, V., Kazakova, M., & Sarafian, V. S. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0100 · Cited by 34
Lupeol Isolated from Betula alnoides Ameliorates Amyloid Beta Induced Neuronal Damage via Targeting Various Pathological Events and Alteration in Neurotransmitter Levels in Rat’s Brain
Kaundal, M., Akhtar, M., & Deshmukh, R. R. (2017) · Journal of Neurology and Neuroscience · doi:10.21767/2171-6625.1000195 · Cited by 32
Protein phosphatase 2ACα gene knock-out results in cortical atrophy through activating hippo cascade in neuronal progenitor cells
Liu, B., Sun, L.-H., Huang, Y.-F., Guo, L.-J., & Luo, L.-S. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.12.015 · Cited by 29
“According to the previous studies, the inhibition of PP2A gene expression has been proven to lead to the de-regulation of a lot of Ser/Thr kinases including GSK3β, ERK1/2 and JNK, which contributes to cytoskeleton abnormality, alteration of phosphorylated status of tau protein, generation of amyloidal precursor protei…”
Background
Novel Neuroprotective Function of Apical-Basal Polarity Gene Crumbs in Amyloid Beta 42 (Aβ42) Mediated Neurodegeneration
Steffensmeier, A. M., Tare, M., Puli, O. R., Modi, R. M., Nainaparampil, J. J., Kango‐Singh, M., & Singh, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078717 · Cited by 31
“The abnormal cleavage of APP causes the protein to be 42 amino acids long (Ab42), whereas, the normal length of the protein is 40 amino acids long (Ab40) [1,2,7,8].”
Chitinase1 contributed to a potential protection via microglia polarization and Aβ oligomer reduction in D-galactose and aluminum-induced rat model with cognitive impairments
Xiao, Q., Yu, W., Tian, Q., Fu, X. L., Wang, X., Gu, M., & Lü, Y. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.04.050 · Cited by 30
A functional variant in the miR‐142 promoter modulating its expression and conferring risk of Alzheimer disease
Ghanbari, M., Munshi, S. T., Ma, B., Lendemeijer, B., Bansal, S., Adams, H. H. H., Wang, W., Goth, K., Slump, D. E., van den Hout, M. C. G. N., et al. (2019) · Human Mutation · doi:10.1002/humu.23872 · Cited by 31
Hippo signaling: bridging the gap between cancer and neurodegenerative disorders
Singh, A., Gogia, N., Chimata, A. V., Deshpande, P., & Singh, A. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.295273 · Cited by 31
Osthole Upregulates BDNF to Enhance Adult Hippocampal Neurogenesis in APP/PS1 Transgenic Mice
Liu, H., Xue, X., Shi, H., Qi, L., & Gong, D. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00013 · Cited by 31
Identification of Pre-symptomatic Gene Signatures That Predict Resilience to Cognitive Decline in the Genetically Diverse AD-BXD Model
Neuner, S. M., Heuer, S. E., Zhang, J., Philip, V. M., & Kaczorowski, C. C. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00035 · Cited by 29
Remimazolam attenuates lipopolysaccharide-induced neuroinflammation and cognitive dysfunction
Zhou, L., Shi, H., Xiao, M., Liu, W., Wang, L., Zhou, S., Chen, S., Wang, Y., & Liu, C. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115268 · Cited by 31
“Previous studies have established that neuronal death and hippocampal damage serve as pathological bases for cognitive dysfunction[37].”
Background
Melatonin and Sleep Disturbances in Alzheimer’s Disease
Prodhan, A. H. M. S. U., Cavestro, C., Kamal, M. A., & Islam, M. A. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210804155617 · Cited by 30
Targeting Death-Associated Protein Kinases for Treatment of Human Diseases: Recent Advances and Future Directions
Zhang, L., Luo, B., Lü, Y., & Chen, Y. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01606 · Cited by 30
Amyloid-induced neurodegeneration: A comprehensive review through aggregomics perception of proteins in health and pathology
Bashir, S., Aiman, A., Shahid, M., Chaudhary, A. A., Sami, N., Basir, S. F., Hassan, M. I., & Islam, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102276 · Cited by 31
The Role of Glial Fibrillary Acidic Protein in the Neuropathology of Alzheimer’s Disease and Its Potential as a Blood Biomarker for Early Diagnosis and Progression
Bandara, E. M. S., Asih, P. R., Pedrini, S., Hone, E., Fernando, W. M. A. D. B., & Martins, R. N. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05219-3 · Cited by 37
Behavioral, neuromorphological, and neurobiochemical effects induced by omega-3 fatty acids following basal forebrain cholinergic depletion in aged mice
Cutuli, D., Landolfo, E., Nobili, A., Bartolo, P. D., Sacchetti, S., Chirico, D., Marini, F., Pieroni, L., Ronci, M., D’Amelio, M., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00705-3 · Cited by 30
Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and Neurodegeneration
Mehan, S., Bhalla, S., Siddiqui, E. M., Sharma, N., Shandilya, A., & Khan, A. (2022) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s247153 · Cited by 29
“When oligo polymerizes and clumps, plaques are formed.(24,25) A40 and A42 are two types of Aβ polymers that play a significant role in the pathogenesis of dementia.”
The potential of the gut microbiome for identifying Alzheimer’s disease diagnostic biomarkers and future therapies
Zhan, Y., Al‐Nusaif, M., Ding, C., Zhao, L., & Dong, C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1130730 · Cited by 31
“The presence of activated microglia and reactive astrocytes in the vicinity of amyloid plaques is characteristic of AD neuroinflammation, mainly in the hippocampus (Crews and Masliah, 2010; Cattaneo et al., 2017).”
Background
Tacrine, Trolox and Tryptoline as Lead Compounds for the Design and Synthesis of Multi-target Agents for Alzheimer’s Disease Therapy
Teponnou, G. A. K., Joubert, J., & Malan, S. F. (2017) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104501711010024 · Cited by 29
“Current hypotheses suggest a decrease in the level of the neurotransmitter acetylcholine (ACh) in the brain regions involved in learning and memory, β-amyloid plaque formation (Aβ), oxidative stress, excitotoxicity, neuroinflammation and aggregation of tau proteins (τ-proteins) [5, 6].”
PET/CT of Dementia
Zukotynski, K., Kuo, P. H., Mikulis, D. J., Rosa‐Neto, P., Strafella, A. P., Subramaniam, R. M., & Black, S. E. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.18.19822 · Cited by 31
Preclinical to phase II amyloid beta (Aβ) peptide modulators under investigation for Alzheimer’s disease
Parsons, C. G., & Rammes, G. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1313832 · Cited by 29
“To this day, the exact assembly state (s) and conformation(s) of the particular oligomers that are most toxic are still not clear [107].”
Background
Medical foods in Alzheimer’s disease
Lange, K. W., Guo, J., Kanaya, S., Lange, K. M., Nakamura, Y., & Li, S. (2019) · Food Science and Human Wellness · doi:10.1016/j.fshw.2019.02.002 · Cited by 30
Inhibition of inflammatory mediators and cell migration by 1,2,3,4-tetrahydroquinoline derivatives in LPS-stimulated BV2 microglial cells via suppression of NF-κB and JNK pathway
Bui, B. P., Oh, Y., Lee, H., & Cho, J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106231 · Cited by 28
Procyanidin B2 inhibits lipopolysaccharide‑induced apoptosis by suppressing the Bcl‑2/Bax and NF‑κB signalling pathways in human umbilical vein endothelial cells
Song, D., Liu, J., Wang, F., Li, X., Liu, M., Zhang, Z., Cao, S., & Jiang, X. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11906 · Cited by 28
Alzheimer’s disease and sleep disorders: Insights into the possible disease connections and the potential therapeutic targets
Marde, V. S., Atkare, U. A., Gawali, S. V., Tiwari, P. L., Badole, S. P., Wankhede, N. L., Taksande, B. G., Upaganlawar, A., Umekar, M. J., & Kale, M. B. (2021) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2021.102961 · Cited by 29
How Does p73 Cause Neuronal Defects?
Niklison-Chirou, M. V., Killick, R., Knight, R. A., Nicotera, P., Melino, G., & Agostini, M. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9381-1 · Cited by 29
“Indeed, few would argue β-amyloid does not play an important role in the etiology and pathology of the disease, and the general consensus now is that it is not the amyloid aggregates themselves but rather the oligomeric, soluble forms of β-amyloid that are the toxic species, exerting effects on a multitude of cellular…”
Background
Ciliary neurotrophic factor protects SH-SY5Y neuroblastoma cells against Aβ 1-42 -induced neurotoxicity via activating the JAK2/STAT3 axis
Wang, K., Xie, M., Zhu, L., Zhu, X., Zhang, K., & Zhou, F. (2015) · Folia Neuropathologica · doi:10.5114/fn.2015.54423 · Cited by 28
“Amyloid β clusters into amyloid plaques on the blood vessels and the outer surface of neurons of the brain, leading to the killing of neurons [10].”
Background
ZiBu PiYin recipe prevents diabetes-associated cognitive decline in rats: possible involvement of ameliorating mitochondrial dysfunction, insulin resistance pathway and histopathological changes
Sun, Z., Zhan, L., Liang, L., Sui, H. X., Zheng, L., Sun, X., & Xie, W. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1177-y · Cited by 28
“Maintaining mitochondrial function is essential for neuron survival and offers protection against neurodegeneration [33–36].”
Background
Ketamine-induced neurotoxicity blocked by N -Methyl- d -aspartate is mediated through activation of PKC/ERK pathway in developing hippocampal neurons
Jiang, S., Li, X., Jin, W., Duan, X., Bo, L., Jiang-li, W., Zhang, R., Wang, Y., Kang, R., & Huang, L. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.02.051 · Cited by 27
Fluorescent Biosensor of CDK5 Kinase Activity in Glioblastoma Cell Extracts and Living Cells
Peyressatre, M., Laure, A., Pellerano, M., Boukhaddaoui, H., Soussi, I., & Morris, M. C. (2020) · Biotechnology Journal · doi:10.1002/biot.201900474 · Cited by 27
“The importance of CDK5 in neuronal functions is underscored by the impact of its dysregulation, CDK5 hyperactivation contributing to several neurodegenerative diseases, including Alzheimer’s, Parkinson’s, Huntington’s and amyotrophic lateral sclerosis [14-16].”
Background
Study insights in the role of PGC-1α in neurological diseases: mechanisms and therapeutic potential
Tang, M., Liu, Y., Hu, Z., Luo, H., Zhang, S., Shi, C.-H., & Xu, Y.-M. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1454735 · Cited by 29
Cognitive resilience in Alzheimer’s disease: Mechanism and potential clinical intervention
Jia, B., Xu, Y., & Zhu, X. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102711 · Cited by 30
Optogenetics-induced activation of glutamate receptors improves memory function in mice with Alzheimer’s disease
Yang, X., Zou, L., Wang, K., Ye, X.-L., & Huang, T. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.262593 · Cited by 28
Modulation of hepatic amyloid precursor protein and lipoprotein receptor-related protein 1 by chronic alcohol intake: Potential link between liver steatosis and amyloid-β
Garcia, J., Chang, R., Steinberg, R. A., Arce, A., Yang, J., Eb, P. V. D., Abdullah, T., Chandrashekar, D. V., Eck, S. M., Meza, P., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.930402 · Cited by 26
“The main hallmarks of AD are Aβ deposition, phosphorylated tau containing neurofibrillary tangles, neuronal loss and microgliosis (Crews and Masliah, 2010).”
Background
How does apolipoprotein E genotype influence the relationship between physical activity and Alzheimer’s disease risk? A novel integrative model
de Frutos‐Lucas, J., Sewell, K. R., García‐Colomo, A., Markovic, S. J., Erickson, K. I., & Brown, B. M. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01170-4 · Cited by 26
Impact of seed amplification assay and surface-enhanced Raman spectroscopy combined approach on the clinical diagnosis of Alzheimer’s disease
D’Andrea, C., Cazzaniga, F. A., Bistaffa, E., Barucci, A., de Angelis, M., Banchelli, M., Farnesi, E., Polykretis, P., Marzi, C., Indaco, A., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00367-9 · Cited by 27
Subcellular Distribution of HDAC1 in Neurotoxic Conditions Is Dependent on Serine Phosphorylation
Zhu, Y., Vidaurre, Ó. G., Adula, K. P., Kezunovic, N., Wentling, M., Huntley, G. W., & Casaccia, P. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3000-16.2017 · Cited by 28
“Axonal damage is a common pathological feature of several neurodegenerative disorders, including multiple sclerosis, Parkinson’s disease, and Alzheimer’s disease (Crews and Masliah, 2010; Burke and O’Malley, 2013; Friese et al., 2014).”
Background
The Mechanistic Role of Bridging Integrator 1 (BIN1) in Alzheimer’s Disease
Gao, P.-R., Ye, L., Cheng, H.-R., & Li, H. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00926-y · Cited by 34
Thioperamide attenuates neuroinflammation and cognitive impairments in Alzheimer's disease via inhibiting gliosis
Wang, J., Liu, B., Xu, Y. X., Luan, H., Wang, C., Yang, M., Zhao, R., Song, M., Liu, J., Sun, L., et al. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113870 · Cited by 26
Impact of the Cannabinoid System in Alzheimer's Disease
Li, S., Huang, Y., Yu, L., Ji, X., & Wu, J. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220201091006 · Cited by 28
“3233/JAD-2010-100357 PMID: 20463403 [7] Crews, L.”

Authors: Crews, L., & Masliah, E.
Affiliations: University of California San Diego (US)
Corresponding author: Masliah, E.
ORCID: Crews, L.
Masliah, E.
Venue: Human Molecular Genetics
Publisher: Oxford University Press (OUP)
Published: 2010-04-15
Volume: 19
Issue: R1
Pages: R12-R20
ISSN: 0964-6906 (ISSN-L)
1460-2083
DOI: 10.1093/hmg/ddq160
PMC: PMC2875049
OpenAlex: W2135957529
Cited by: 772
References: 175
Citations by year: 2026: 33 · 2025: 53 · 2024: 56 · 2023: 71 · 2022: 48 · 2021: 76 · 2020: 69 · 2019: 50 · 2018: 47 · 2017: 47 · 2016: 42 · 2015: 34 · 2014: 31 · 2013: 35 · 2012: 40
FWCI: 3.70
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Human Molecular Genetics (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (AG5131, NS4 4233, AG‐18440, AG10435, AG11385)
National Institute on Aging (P01AG010435, AG-11385, P50AG005131, AG-5131, AG 18440, AG10435)
National Institute of Neurological Disorders and Stroke (P01NS044233, NS-44233)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, neurodegeneration, amyloid-beta oligomers, amyloid plaques, tau hyperphosphorylation, neurofibrillary tangles, synaptic loss, adult hippocampal neurogenesis, glutamate receptors, excitotoxicity, mitochondrial dysfunction, lysosomal dysfunction, synaptic plasticity, Fyn, glycogen synthase kinase-3β, cyclin-dependent kinase 5, anti-aggregation therapy, amyloid-beta clearance
MeSH terms: Alzheimer Disease, Humans, Amyloid beta-Peptides, Neurogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular mechanisms of neurodegeneration in Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks